Myriad Genetics introduces online prenatal genetic testing resource
Myriad Genetics (MYGN) has launched a new educational website providing comprehensive information about reproductive and prenatal genetic ...
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online ...
openaccessgovernment2d
NHS genetic testing programme could potentially offer lifesaving cancer prevention
A new NHS genetic testing programme has identified hundreds of people with Jewish ancestry at increased risk of cancer ...